{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:36:54Z","timestamp":1790617014800,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/19138-5"],"award-info":[{"award-number":["2014\/19138-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Diseases of the anterior segment of the eye may present different mechanisms, intensity of symptoms, and impact on the patients\u2019 quality of life and vision. The tear film is in direct contact with the ocular surface and cornea and can be easily accessed for sample collection, figuring as a promising source of potential biomarkers for diagnosis and treatment control. This study aimed to evaluate tear proteomic profile in 3 distinct ocular diseases: keratoconus (corneal ectasia), severe dry eye related to graft-versus-host-disease (tear film dysfunction and ocular inflammatory condition) and pterygium (conjunctival fibrovascular degenerative disease).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Tear samples were collected from patients of each condition and a control group. By using mass spectrometric analysis combined with statistics and bioinformatics tools, a detailed comparison of protein profile was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After Student\u2019s t-test analyses comparing each condition to the control group, we found the following number of differentially expressed proteins: 7 in keratoconus group, 29 in pterygium group, and 79 in GVHD group. Following multivariate analyses, we also report potential candidates as biomarkers for each disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We demonstrated herein that mass spectrometry-based proteomics was able to indicate proteins that differentiate three distinct ocular conditions, which is a promising tool for the diagnosis of ocular diseases.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12014-020-09307-5","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T12:04:20Z","timestamp":1607342660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Tear proteomic profile in three distinct ocular surface diseases: keratoconus, pterygium, and dry eye related to graft-versus-host disease"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2879-7950","authenticated-orcid":false,"given":"Daniel","family":"de Almeida Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Rodrigo","family":"Alborghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Franco Paes Leme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romenia","family":"Ramos Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Trindade Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia","family":"Viana Wanzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Leite Arieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"9307_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.exer.2013.07.015","volume":"117","author":"N von Thun und Hohenstein-Blaul","year":"2013","unstructured":"von Thun und Hohenstein-Blaul N, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases. Exp Eye Res. 2013;117:126\u201337.","journal-title":"Exp Eye Res"},{"issue":"6","key":"9307_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.preteyeres.2012.06.002","volume":"31","author":"L Zhou","year":"2012","unstructured":"Zhou L, Beuerman RW. Tear analysis in ocular surface diseases. Prog Retin Eye Res. 2012;31(6):527\u201350.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"9307_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/prca.200700105","volume":"1","author":"FH Grus","year":"2007","unstructured":"Grus FH, Joachim SC, Pfeiffer N. Proteomics in ocular fluids. Proteomics Clin Appl. 2007;1(8):876\u201388.","journal-title":"Proteomics Clin Appl"},{"issue":"6928","key":"9307_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198\u2013207.","journal-title":"Nature"},{"key":"9307_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.euprot.2014.02.016","volume":"3","author":"N Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez N, Iloro I, Soria J, Duran JA, Santamar\u00eda A, Elortza F, et al. Human tear peptide\/protein profiling study of ocular surface diseases by SPE-MALDI-TOF mass spectrometry analyses. EuPA Open Proteomics. 2014;3:206\u201315.","journal-title":"EuPA Open Proteomics"},{"issue":"July","key":"9307_CR6","first-page":"1","volume":"6","author":"N Perumal","year":"2016","unstructured":"Perumal N, Funke S, Pfeiffer N, Grus FH. Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients. Sci Rep. 2016;6(July):1\u201312.","journal-title":"Sci Rep"},{"issue":"1","key":"9307_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1167\/iovs.13-12080","volume":"55","author":"B Li","year":"2014","unstructured":"Li B, Sheng M, Xie L, Liu F, Yan G, Wang W, et al. Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. Investig Ophthalmol Vis Sci. 2014;55(1):177\u201386.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"September","key":"9307_CR8","first-page":"1949","volume":"16","author":"C Pannebaker","year":"2010","unstructured":"Pannebaker C, Chandler HL, Nichols JJ. Tear proteomics in keratoconus. Mol Vis. 2010;16(September):1949\u201357.","journal-title":"Mol Vis"},{"issue":"September","key":"9307_CR9","first-page":"2055","volume":"16","author":"I Lema","year":"2010","unstructured":"Lema I, Brea D, Rodr\u00edguez-Gonz\u00e1lez R, D\u00edez-Feijoo E, Sobrino T. Proteomic analysis of the tear film in patients with keratoconus. Mol Vis. 2010;16(September):2055\u201361.","journal-title":"Mol Vis"},{"key":"9307_CR10","first-page":"2124","volume":"19","author":"SA Balasubramanian","year":"2013","unstructured":"Balasubramanian SA, Wasinger VC, Pye DC, Willcox MDP. Preliminary identification of differentially expressed tear proteins in keratoconus. Mol Vis. 2013;19:2124\u201334.","journal-title":"Mol Vis"},{"issue":"8","key":"9307_CR11","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1167\/iovs.18-24433","volume":"59","author":"NG Hollbach","year":"2018","unstructured":"Hollbach NG, Plattner K, O\u2019Leary OE, Jenoe P, Moes S, Drexler B, et al. Tear film proteomics reveal important differences between patients with and without ocular GvHD after allogeneic hematopoietic cell transplantation. Investig Ophthalmol Vis Sci. 2018;59(8):3521\u201330.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"9307_CR12","first-page":"2019","volume":"7","author":"J Vazirani","year":"2013","unstructured":"Vazirani J, Basu S. Keratoconus: Current perspectives. Clin Ophthalmol. 2013;7:2019\u201330.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"9307_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0039-6257(97)00119-7","volume":"42","author":"YS Rabinowitz","year":"1998","unstructured":"Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42(4):297\u2013320.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"9307_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"Suppl 1","key":"9307_CR15","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/00003226-200310001-00004","volume":"22","author":"Y Ogawa","year":"2003","unstructured":"Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea. 2003;22(Suppl 1):S19-27.","journal-title":"Cornea"},{"issue":"1","key":"9307_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1542-0124(12)70103-9","volume":"6","author":"J Chui","year":"2008","unstructured":"Chui J, di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf. 2008;6(1):24\u201343.","journal-title":"Ocul Surf"},{"issue":"6","key":"9307_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S0161-6420(03)00261-6","volume":"110","author":"M Dogru","year":"2003","unstructured":"Dogru M, Karakaya H, \u00d6z\u00e7etin H, Ert\u00fcrk H, Y\u00fccel A, \u00d6zmen A, et al. Tear function and ocular surface changes in keratoconus. Ophthalmology. 2003;110(6):1110\u20138.","journal-title":"Ophthalmology"},{"issue":"12","key":"9307_CR18","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/ICO.0b013e318259c934","volume":"31","author":"G Julio","year":"2012","unstructured":"Julio G, Lluch S, Pujol P, Alonso S, Merindano D. Tear osmolarity and ocular changes in pterygium. Cornea. 2012;31(12):1417\u201321.","journal-title":"Cornea"},{"issue":"5","key":"9307_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.survophthal.2018.03.001","volume":"63","author":"F Rezvan","year":"2018","unstructured":"Rezvan F, Khabazkhoob M, Hooshmand E, Yekta A, Saatchi M, Hashemi H. Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Surv Ophthalmol. 2018;63(5):719\u201335.","journal-title":"Surv Ophthalmol"},{"issue":"November","key":"9307_CR20","first-page":"1","volume":"5","author":"FV Winck","year":"2015","unstructured":"Winck FV, Ribeiro ACP, Domingues RR, Ling LY, Ria\u00f1o-Pach\u00f3n DM, Rivera C, et al. Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Sci Rep. 2015;5(November):1\u201313.","journal-title":"Sci Rep"},{"issue":"2","key":"9307_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","volume":"9","author":"J Xia","year":"2013","unstructured":"Xia J, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics. 2013;9(2):280\u201399.","journal-title":"Metabolomics"},{"issue":"D1","key":"9307_CR22","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9307_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0039-6257(84)90094-8","volume":"28","author":"JH Krachmer","year":"1984","unstructured":"Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28(4):293\u2013322.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"9307_CR24","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1167\/iovs.14-14831","volume":"56","author":"R Shetty","year":"2015","unstructured":"Shetty R, Ghosh A, Lim RR, Subramani M, Mihir K, Reshma AR, et al. Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A. Investig Ophthalmol Vis Sci. 2015;56(2):738\u201350.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"9307_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1755-3768.2011.02369.x","volume":"90","author":"SA Balasubramanian","year":"2012","unstructured":"Balasubramanian SA, Mohan S, Pye DC, Willcox MDP. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol. 2012;90(4):303\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"9307_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/eye.2011.105","volume":"25","author":"A Acera","year":"2011","unstructured":"Acera A, Vecino E, Rodr\u00edguez-Agirretxe I, Aloria K, Arizmendi JM, Morales C, et al. Changes in tear protein profile in keratoconus disease. Eye. 2011;25(9):1225\u201333.","journal-title":"Eye"},{"issue":"1","key":"9307_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0016437","volume":"6","author":"AS Jun","year":"2011","unstructured":"Jun AS, Cope L, Speck C, Feng X, Lee S, Meng H, et al. Subnormal cytokine profile in the tear fluid of keratoconus patients. PLoS ONE. 2011;6(1):1\u20138.","journal-title":"PLoS ONE"},{"issue":"02","key":"9307_CR28","first-page":"1","volume":"01","author":"A Michael","year":"2012","unstructured":"Michael A, Hauser JW. The genetics of keratoconus: a review. Reprod Syst Sex Disord. 2012;01(02):1\u20138.","journal-title":"Reprod Syst Sex Disord"},{"issue":"11","key":"9307_CR29","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1021\/pr900686s","volume":"8","author":"L Zhou","year":"2009","unstructured":"Zhou L, Beuerman RW, Choi MC, Shao ZZ, Xiao RL, Yang H, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009;8(11):4889\u2013905.","journal-title":"J Proteome Res"},{"issue":"8","key":"9307_CR30","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1167\/iovs.11-9022","volume":"53","author":"S Srinivasan","year":"2012","unstructured":"Srinivasan S, Thangavelu M, Zhang L, Green KB, Nichols KK. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Investig Ophthalmol Vis Sci. 2012;53(8):5052\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"9307_CR31","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1167\/iovs.11-8751","volume":"54","author":"N Boehm","year":"2013","unstructured":"Boehm N, Funke S, Wiegand M, Wehrwein N, Pfeiffer N, Grus FH. Alterations in the tear proteome of dry eye patients-A matter of the clinical phenotype. Investig Ophthalmol Vis Sci. 2013;54(3):2385\u201392.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"9307_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0106473","volume":"9","author":"KS Na","year":"2014","unstructured":"Na KS, Jee DH, Han K, Park YG, Kim MS, Kim EC. The ocular benefits of estrogen replacement therapy: a population-based study in postmenopausal korean women. PLoS ONE. 2014;9(9):1\u20136.","journal-title":"PLoS ONE"},{"issue":"14","key":"9307_CR33","doi-asserted-by":"publisher","first-page":"DES71","DOI":"10.1167\/iovs.17-23750","volume":"59","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y. Sjogren\u2019s syndrome, non-sjogren\u2019s syndrome, and graft- versus-host disease related dry eye. Invest Ophthalmol Vis Sci. 2018;59(14):DES71\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"9307_CR34","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","volume":"130","author":"NJ Gloude","year":"2017","unstructured":"Gloude NJ, Khandelwal P, Luebbering N, Lounder DT, Jodele S, Alder MN, et al. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood. 2017;130(10):1259\u201366.","journal-title":"Blood"},{"issue":"11","key":"9307_CR35","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","volume":"96","author":"J Qi","year":"2017","unstructured":"Qi J, Wang J, Chen J, Su J, Tang Y, Wu X, et al. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation. Ann Hematol. 2017;96(11):1849\u201355.","journal-title":"Ann Hematol"},{"issue":"2","key":"9307_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1194\/jlr.M044826","volume":"55","author":"SM Lam","year":"2014","unstructured":"Lam SM, Tong L, Duan X, Petznick A, Wenk MR, Shui G. Extensive characterization of human tear fl uid collected using different techniques unravels the presence of novel lipid amphiphiles. J Lipid Res. 2014;55(2):289\u201398.","journal-title":"J Lipid Res"},{"issue":"5","key":"9307_CR37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0004563217695843","volume":"54","author":"A Rentka","year":"2017","unstructured":"Rentka A, Koroskenyi K, Harsfalvi J, Szekanecz Z, Szucs G, Szodoray P, et al. Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis. Ann Clin Biochem. 2017;54(5):521\u20139.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"9307_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/02713683.2010.542867","volume":"36","author":"M Markoulli","year":"2011","unstructured":"Markoulli M, Papas E, Petznick A, Holden B. Validation of the flush method as an alternative to basal or reflex tear collection. Curr Eye Res. 2011;36(3):198\u2013207.","journal-title":"Curr Eye Res"},{"issue":"3","key":"9307_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11306-013-0598-6","volume":"10","author":"E Saccenti","year":"2014","unstructured":"Saccenti E, Hoefsloot HCJ, Smilde AK, Westerhuis JA, Hendriks MMWB. Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics. 2014;10(3):361\u201374.","journal-title":"Metabolomics"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-020-09307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12014-020-09307-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-020-09307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T21:43:10Z","timestamp":1618609390000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-020-09307-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9307"],"URL":"https:\/\/doi.org\/10.1186\/s12014-020-09307-5","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"30 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out with the approval of the Institutional Research Ethics Committee Board (CEP) of UNICAMP (reference number: 55904316.8.0000.5404) and was conducted under the tenets of the Declaration of Helsinki and current legislation on clinical research. Written informed consent was obtained from all subjects after explanation of the procedures and study requirements.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}